The U.S. neurological device market was valued at over $7.6 billion in 2024 and is projected to grow at a CAGR of 3.8%, reaching nearly $10 billion by 2031.
Market growth is driven by:
Advancements in neuromodulation, brain-computer interfaces (BCIs), and AI-powered diagnostics.
Increasing demand for minimally invasive neurovascular interventions.
Expanded indications for neuromodulation in pain management and movement disorders.
Spinal cord stimulation (SCS), deep brain stimulation (DBS), and sacral nerve stimulation (SNS) are key segments.
Closed-loop and AI-driven neuromodulation systems are improving personalized treatment efficacy.
Growing applications in psychiatric disorders and pain management are expanding the market.
Neurovascular Thrombectomy Sees Rapid Expansion:
Advancements in aspiration catheters and stent retrievers enhance procedural efficiency.
Increased adoption of thrombectomy in stroke centers improves acute stroke care.
AI and real-time imaging integration are optimizing clot retrieval outcomes.
U.S. Neurological Device Market Share Insights (2024)
1 Medtronic - Market Leader
Dominant in neuromodulation, liquid embolics, intrathecal pumps, and stereotactic devices.
Faces increasing competition in sacral nerve stimulation from Axonics.
January 2025: Medtronic earns CE Mark approval for BrainSense Adaptive DBS and Electrode Identifier, advancing BCI technology for Parkinson's care.
2 Stryker - Second-Largest Competitor
Strong performance in neurovascular guidewires, detachable coils, and ultrasonic aspirators.
January 2025: Stryker announces definitive agreement to acquire Inari Medical, strengthening its neurovascular portfolio.
Focuses on minimally invasive neurovascular solutions for thrombectomy and aneurysm repair.
3 Abbott - Third-Largest Competitor
Significant presence in neuromodulation with its Infinity(TM) DBS system and BurstDR(TM) spinal cord stimulation.
January 2025: Abbott announces long-term efficacy of BurstDR(TM) SCS in chronic pain treatment, with 91% of patients preferring it over traditional methods.
Introduced NeuroSphere(TM) Digital Health app for remote patient management.
Market Segmentation Summary
Cerebrospinal Fluid (CSF) Market - Further segmented into:
CSF Shunts
CSF External Drainage Systems
Detachable Coil Market - Further segmented into:
Bare Platinum Coils
Coated Coils
Liquid Embolic Market
Neurovascular Catheter Market - Further segmented into:
Over-the-Wire Microcatheters
Flow-Directed Microcatheters
Neurovascular Guiding Catheters
Neurovascular Guidewire Market
Neurovascular Stent Market - Further segmented into:
Traditional Neurovascular Stents
Flow Diversion Stents
Intrasaccular Stents
Balloon Occlusion Device Market
Aneurysm Clip Market - Further segmented into:
Titanium Clips
Cobalt Alloy Clips
Neurovascular Thrombus Management Market - Further segmented into:
Stent Retrievers
Aspiration Catheters
Aspiration Pump Canisters
Neuromodulation Device Market - Further segmented into:
Spinal Cord Stimulation (SCS)
Deep Brain Stimulation (DBS)
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation (VNS)
Gastric Electric Stimulation (GES)
Dorsal Root Ganglion Stimulation (DRG)
Responsive Neurostimulation Devices
Intrathecal Pump Market
Stereotactic Device Market - Further segmented into:
Frame-based Stereotactic Devices
Frameless Stereotactic Devices
Neuroendoscopy Market - Further segmented into:
Rigid Endoscopes
Flexible Endoscopes
Videoscopes
Single-Use Endoscopes
Neuroendoscopic Hand Instruments
Neuroendoscopy Disposables
Ultrasonic Aspirator Market - Further segmented into:
Capital Equipment
Disposable Probe Tips
Disposable Tubing
Handpieces
Accessories
Research Scope Summary
Regions Covered
United States
Base Year: 2024
Forecast Period: 2025-2031
Historical Data: 2021-2023
Quantitative Coverage
Market Size & Growth Rates
Procedure Numbers
Unit Sales & ASP
Market Shares & Forecasts through 2031
Qualitative Coverage
Market Growth Trends & Limiters
Competitive Analysis & SWOT for Top Competitors
Mergers & Acquisitions
Company Profiles & Product Portfolios
FDA Recalls & Regulatory Developments
Disruptive Technologies & Emerging Innovations
Disease Overviews
Data Sources
Primary Interviews with Industry Leaders
Government Physician Data
Regulatory Data
Hospital Private Data
Import & Export Data
iData Research Internal Database
TABLE OF CONTENT
TABLE of CONTENTS
List of Figures
List of Charts
executive summary
Competitive Analysis
Emerging Markets and Technologies
Market Trends
Market Developments
Procedure Segmentation
Market Segmentation
Key Report Updates
Version History
research methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
U.S. Neurological Device Market Overview
2.1 Introduction
2.1.1 Cerebrospinal Fluid Management
2.1.2 Interventional Neuroradiology
2.1.3 Neuromodulation
2.1.4 Neurosurgery
2.1.5 Neurovascular Thrombectomy
2.2 Market Overview & Trend Analysis
2.3 Drivers and Limiters
2.3.1 Market Drivers
2.3.1.1 Cerebrospinal Fluid Management
2.3.1.2 Interventional Neuroradiology
2.3.1.3 Neuromodulation
2.3.1.4 Neurosurgery
2.3.1.5 Neurovascular Thrombectomy
2.3.2 Market Limiters
2.3.2.1 Cerebrospinal Fluid Management
2.3.2.2 Interventional Neuroradiology
2.3.2.3 Neuromodulation
2.3.2.4 Neurosurgery
2.3.2.5 Neurovascular Thrombectomy
2.4 Competitive Market Share Analysis
2.5 Mergers and Acquisitions
Procedure Numbers
3.1 Procedure Analysis and Forecast
3.1.1 Cerebrospinal Fluid Shunting Procedures
3.1.2 Interventional Treatment of Saccular Aneurysm Procedures